WHO ICTRP trial
Anterior cruciate ligament reconstruction: Transtibial method versus…
ChiCTR1800014874 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800014874 |
|---|---|
| Public title | Anterior cruciate ligament reconstruction: Transtibial method versus anteromedial portal approach |
| Scientific title | Anterior cruciate ligament reconstruction: Transtibial method versus anteromedial portal approach |
| Primary sponsor | Yuhuangding Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Anterior cruciate ligament avulsion |
| Interventions | Anteromedial portal group:Anterior cruciate ligament is reconstructed by anteromedial portal.;Transtibial group:Anterior cruciate ligament is reconstructed by transtibial group? |
| Registration date | Feb 12, 2018 |
| Target size | Anteromedial portal group:60;Transtibial group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: